What I get from these two trials is... the drugs d
Post# of 158771
Quote:
What I get from these two trials is... the drugs don't work very well if you have liver mets.
Recall our mcrc patient with a solitary hepatic metastasis underwent liver resection following a reduction (43%) after FOLFOX + leronlimab, and remains alive with no evidence of disease (NED) at ∼57 months.